aggressive triple negative breast cancers, particularly the basal-like and claudin-low subtypes. While EMT signatures contain hundreds of genes, their expression is controlled by core of effector transcription factors…
genotoxic assessments by lymphocyte cultures on 600 persons exposed to MIC gas and various control subjects and family members in Bhopal had also established that chromosomal damages have been installed ... measuring…
identification of patients with early ER+ (estrogen receptor-positive) breast cancer. However, while these markers were absent in controls, the results were obtained from only two patients and therefore require…
that MMPs regulate inflammation in tumor microenvironment, which plays an im-portant role in cancer progression. Looking at both inflammatory and neuronal damag-es, MMP, specially MMP-2 and MMP9 ... those observed in…
ssDNA short fragments were found in plasma of retinoblastoma patient. To the contrast, in control donors, a smaller population of ssDNA (2.40 – 2.82 ng x mL-1) was found consisting ... technique allows to reveal the…
understand the varied risk of developing complications of diabetes with similar levels of glycemic control, how nonglycemic effects of some medications for diabetes result in marked complication risk modification…
cancer cells in vivo. Recent Publications 1. Wojcicki, A. et al. (2012). Hyaluronic acid-bearing lipoplexes: Physico-chemical characterization and in vitro targeting of the CD44 receptor. J Control Release…
that microgels are used clinically, e.g., to deliver doxorubicin in the treatment of liver cancer [1], little attention has been given to how the drug self-assembly inside microgels affects ... bead investigation of a…
several drugs, and enabled drug targeting to diseased tissues, especially in the field of cancer treatment. However, a widespread use of nanomedicine still faces several important impediments, especially ... lipids or…
treatment of their particular disease(s). With precision therapeutics, the aim is to take control of the delivery of APIs to disease target tissue, by means of nanomedicine ... treatment of chronic diseases. Chronic…
explore the possible development of a new nanomedicine technology that uses anti-cancer drug doped-nanoparticles (Figure a) to kill tumour cells. Nanoparticles1 are held in solution which can lead ... Morrow, K…
factor-α (TNF-α) and CD40 ligand (CD40L) to genetically modify MSCs for enhanced cancer therapy. Both DCs and MSCs were isolated from BALB/c mice. DCs were then cocultured ... were co-treated with DCs and/ or…
conjugated nanoparticles against VEGF and CD90 showed signifi cant differences in comparison to pathological control; both achieved signifi cant decrease in all serum parameters, containing AFP, caspases-3, VEGF…
control their symptoms; it gains popularity among diabetes patients to manage the glycemic control. Though some side effects are observed initially, but in the long term it is scientifically proved ... help in the…
measurable changes in gut microbiome functionality occur in CF patients compared to controls), aging, response to cancer treatment, lipid metabolism. The gut healthy microbiome is able to convert lipids, including
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.